CYL-57597-68913
4 vaccinations
5 coded responses
26 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 209 / MD
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
KWU-21941-45268
Child or adolescent in my care · Male · 2022-07-15
Timeline
-
2021-04-19
Registered in v-safe
-
2021-04-19
Dose 1 — Pfizer-BioNTech
- 2021-04-19
- 2021-04-20
- 2021-04-21
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-28
Health check-in — day 7, dose 1Feeling: Poor · Fever · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-03
Survey response — day 14, dose 1MedDRA: Fatigue, Somnolence — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Tiredness/sleepiness for daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Dose 2 — Pfizer-BioNTech
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-15
-
2021-05-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to workAdult check-in
- 2021-05-19
-
2021-05-28
Survey response — day 14, dose 2MedDRA: Fatigue, Rhinorrhoea — Feeling: Fair · Be unable to workFree text: Runny nose the last few days and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-02
- 2021-06-09
- 2021-06-16
-
2021-08-11
Survey response — 3 months, dose 2MedDRA: Fatigue, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tiredness, cold symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-11
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2022-05-13
-
2022-06-08
Dose 4 — Pfizer-BioNTech
- 2022-06-15
- 2022-06-15
- 2022-06-28
-
2022-07-15
Survey response — day 35, dose 4MedDRA: Brain fog, Headache, Rhinorrhoea — Feeling: FairFree text: Haziness, runny nose, some headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-07-26
- 2022-09-11
-
2022-12-09
Survey response — 6 months, dose 4MedDRA: Nasopharyngitis — Feeling: GoodFree text: ColdsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | |
| 2 | 2021-05-12 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-06-08 | Pfizer-BioNTech | No |
Free text
Release 8 — day 14, dose 1
Symptoms: Tiredness/sleepiness for days
Release 8 — day 14, dose 2
Symptoms: Runny nose the last few days and fatigue
Release 9 — 3 months, dose 2
Symptoms: Tiredness, cold symptoms
Release 12 — day 35, dose 4
Symptoms: Haziness, runny nose, some headache
Release 12 — 6 months, dose 4
Symptoms: Colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Somnolence | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release